Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ARCT Arcturus Therapeutics Ltd.

Post-Mkt 09-18 19:16:56 EDT

16.03

-0.90

-5.32%

盘后16.10

+0.07+0.44%

19:01 EDT

High17.75	Low15.92	Vol841.47K
Open16.69	D1 Closing16.93	Amplitude10.81%
Mkt Cap455.45M	Tradable Cap421.19M	Total Shares28.41M
T/O13.79M	T/O Rate3.20%	Tradable Shares26.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":16.03,"timestamp":1789761600000,"preClose":16.93,"halted":0,"volume":841468,"hourTrading":{"tag":"盘后","latestPrice":16.1,"preClose":16.03,"latestTime":"19:01 EDT","volume":82748,"amount":1326449.695268,"timestamp":1789772464733,"change":0.07,"changeRate":0.004367,"amplitude":0.004398},"delay":0,"changeRate":-0.053160070880094425,"floatShares":26275300,"shares":28412537,"eps":-3.328942,"marketStatus":"Post-Mkt","change":-0.9,"latestTime":"09-18 19:16:56 EDT","open":16.685,"high":17.75,"low":15.92,"amount":13789767.217,"amplitude":0.108092,"askPrice":16.5,"askSize":1000,"bidPrice":15.93,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.328942,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789776000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":16.93,"preHourTrading":{"tag":"盘前","latestPrice":16.54,"preClose":16.93,"latestTime":"09:29 EDT","volume":7438,"amount":126661.38216599998,"timestamp":1789738169103,"change":-0.39,"changeRate":-0.023036,"amplitude":0.148866},"postHourTrading":{"tag":"盘后","latestPrice":16.1,"preClose":16.03,"latestTime":"19:01 EDT","volume":82748,"amount":1326449.695268,"timestamp":1789772464733,"change":0.07,"changeRate":0.004367,"amplitude":0.004398},"volumeRatio":1.106343,"impliedVol":1.0539,"impliedVolPercentile":0.4701},"requestUrl":"/m/hq/s/ARCT","defaultTab":"news","newsList":[{"id":"2668263019","title":"Arcturus to Present Phase 2 ARCT-810 Clinical Data in OTC Deficiency on Sept. 23","url":"https://stock-news.laohu8.com/highlight/detail?id=2668263019","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668263019?lang=en_us&edition=fundamental","pubTime":"2026-09-18 21:01","pubTimestamp":1789736478,"startTime":"0","endTime":"0","summary":"Arcturus to present Phase 2 ARCT-810 clinical data in OTC deficiency on Sept. 23Arcturus scheduled a virtual event for Sept. 23, 2026 to present Phase 2 data for ARCT-810 in OTC deficiency.Results hav","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL6rNVMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668389926","title":"Arcturus Therapeutics to Present Ornithine Transcarbamylase (Otc) Deficiency Phase 2 Clinical Data and Provide Update on Mrna Liver Therapeutics Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2668389926","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668389926?lang=en_us&edition=fundamental","pubTime":"2026-09-18 21:00","pubTimestamp":1789736401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUA51RLT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560219","title":"Citi Keeps Their Hold Rating on Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560219","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560219?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:05","pubTimestamp":1789038319,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Citi maintained a Hold rating on Arcturus Therapeutics, with a price target of $8.00. The company’s shares clo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-hold-rating-on-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-keeps-their-hold-rating-on-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664389543","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT) and EyePoint Pharmaceuticals (EYPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664389543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664389543?lang=en_us&edition=fundamental","pubTime":"2026-09-02 12:30","pubTimestamp":1788323420,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Arcturus Therapeutics (ARCT) and EyePoint Pharmaceuticals (EYPT)....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcturus-therapeutics-arct-and-eyepoint-pharmaceuticals-eypt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcturus-therapeutics-arct-and-eyepoint-pharmaceuticals-eypt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","HCSG","BK4585","LABU","LU0109394709.USD","BK4137","LU0029874061.USD","XBI","EYPT","LU0320765992.SGD","LU0889565916.HKD","LU2324357040.USD","BK4588","BK4581","LU0128526141.USD","ARCT","BK4007","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664888177","title":"Arcturus Therapeutics to Present at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664888177","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664888177?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:01","pubTimestamp":1788206499,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics to present at H.C. Wainwright Global Investment ConferenceArcturus Therapeutics will join a series of investor conferences in September 2026, starting with Wells Fargo’s Healthca","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLb6z4sZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","LU1668664300.SGD","LU2125154778.USD","LU1366192091.USD","BK4207","LU1162221912.USD","LU1201861249.SGD","LU2236285917.USD","LU2456880835.USD","ARCT","IYF","LU1244550494.USD","LU1144417596.USD","LU0130102774.USD","LU1244550221.USD","LU2417539215.USD","LU1244550577.SGD","LU1506573853.SGD","BK4566","LU0980610538.SGD","LU1267930227.SGD","LU0072461881.USD","BK4585","LU0310800965.SGD","BK4588","LU0162691827.USD","LU0203347892.USD","BK4559","LU0648001328.SGD","LU0098860793.USD","FTXO","LU1074936037.SGD","LU2125154935.USD","BK4504","TFNS","BK4139","LU0106831901.USD","LU0320765646.SGD","LU1791807156.HKD","BK4534","LU2462157665.USD","LU0052756011.USD","LU0203345920.USD","IE00BSNM7G36.USD","LU0170899867.USD","LU0128525689.USD","LU0314106906.USD","LU2360032135.SGD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716124","title":"Roth MKM Sticks to Their Buy Rating for Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716124?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:55","pubTimestamp":1787745335,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Adam Walsh reiterated a Buy rating on Arcturus Therapeutics today and set a price target of $20.00. According to TipRanks, Walsh i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-their-buy-rating-for-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-sticks-to-their-buy-rating-for-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660893052","title":"Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660893052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660893052?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:20","pubTimestamp":1787224836,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX","BK4141","ARCT","BK4139","NA","BK4104","EQPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911401","title":"Analysts’ Opinions Are Mixed on These NA Stocks: Cardinal Infrastructure Group, Inc. (CDNL), Arcturus Therapeutics (ARCT) and Ceribell, Inc. (CBLL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911401?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:40","pubTimestamp":1786462820,"startTime":"0","endTime":"0","summary":"Companies in the NA sector have received a lot of coverage today as analysts weigh in on Cardinal Infrastructure Group, Inc. (CDNL), Arcturus Thera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-na-stocks-cardinal-infrastructure-group-inc-cdnl-arcturus-therapeutics-arct-and-ceribell-inc-cbll-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-na-stocks-cardinal-infrastructure-group-inc-cdnl-arcturus-therapeutics-arct-and-ceribell-inc-cbll-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4129","BK4082","BK4141","BK4139","NA","CBLL","CDNL","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657966308","title":"Arcturus Therapeutics Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657966308","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657966308?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:01","pubTimestamp":1786050109,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc reports results for the quarter ended June 30 - Earnings SummaryArcturus Therapeutics Holdings IncARCT.OQreported a quarterly adjusted loss of 84 cents per share for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657060","title":"Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657060","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657060?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:12","pubTimestamp":1786047154,"startTime":"0","endTime":"0","summary":"Arcturus Q2 revenue falls sharply on CSL Seqirus deal endOverviewMessenger RNA medicines company's Q2 revenue fell sharply yr/yr due to CSL Seqirus collaboration terminationQ2 net loss widened yr/yr, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4534","BK7501","IDNA","MRNX","BK4532","MRNY","LGHT","BK4585","BK4548","BK4501","BK4533","BK4588","WDNA","BK4551","BK7511","BK4568","BK4139","BK7508","CSL.AU","GNOM","BK7067","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652763","title":"Arcturus Therapeutics Q2 Net Income USD -23.785 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652763","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652763?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:02","pubTimestamp":1786046521,"startTime":"0","endTime":"0","summary":"BRIEF-Arcturus Therapeutics Q2 Net Income USD -23.785 MillionAug 06 (Reuters) - Arcturus Therapeutics Q2 operating income USD -25.545 million.Q2 basic EPS USD -0.84Q2 operating expenses USD 28.504 millionQ2 collaboration revenue USD 880 thousand","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXBKKQBM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652254","title":"Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652254?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUAB45HMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657814560","title":"Arcturus Therapeutics Holdings Inc Expected to Post a Loss of 100 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657814560","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657814560?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:32","pubTimestamp":1785879127,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics Holdings Inc <ARCT.OQ> expected to post a loss of100cents a share - Earnings PreviewArcturus Therapeutics Holdings IncARCT.OQARCT.Ois expected to  show a fall in quarterly revenu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44138U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655876008","title":"Arcturus Therapeutics Updates Financial Calendar with Upcoming Q2 Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2655876008","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655876008?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:01","pubTimestamp":1785268916,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics updates financial calendar with upcoming Q2 results release and conference callArcturus will release Q2 results for the period ended June 30, 2026 on Aug. 6, 2026.A conference ca","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL7ZwBlb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655887670","title":"Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655887670","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655887670?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:01","pubTimestamp":1785268860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA6HCXRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653243721","title":"Arcturus Therapeutics to Present at the Canaccord Genuity 46TH Annual Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2653243721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653243721?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:01","pubTimestamp":1784577660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUA3YYHSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651439900","title":"Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651439900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651439900?lang=en_us&edition=fundamental","pubTime":"2026-07-15 12:30","pubTimestamp":1784089846,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fisher & Paykel Healthcare Corporation Limited (FSPKF) and Arctur...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fisher-paykel-healthcare-corporation-limited-otherfspkf-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FSPKF","ARCT","FPH.NZ","BK4585","BK8004","XLV","BK4581","XBI","BK4082","BK4588","LABU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648068125","title":"U.S. Stocks on the Move-silicom, Blue Owl, Intel","url":"https://stock-news.laohu8.com/highlight/detail?id=2648068125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648068125?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:19","pubTimestamp":1783009173,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Silicom, Blue Owl, IntelWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL6N4341RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDK","UHS","SNDQ","NEXA","HCA","INTC","HSBA.UK","LINT","SILC","YRD","NWMX","KLAG","TMO","GE","WBX","OUST","SNXX","RVNL","LCDL","OWL","FC","CLRO","MRNY","TERG","DLTR","LCIZ","HONA","TER","NEM","ONTO","JPMO","ARCT","CWD","MRNA","KLAC","ELTX","LHAI","JPO","SNDU","FPS","MRNX","INTW","RIVN","AU","CVEO","LCID","SNDG","SNDC","MEI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648681913","title":"Analysts Offer Insights on Healthcare Companies: Faeth Therapeutics (FTH) and Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648681913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648681913?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:10","pubTimestamp":1783008609,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Faeth Therapeutics (FTH) and Arcturus Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-faeth-therapeutics-fth-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-faeth-therapeutics-fth-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","ARCT","XBI","LU0128526141.USD","BK4588","XLV","LU0029874061.USD","BK4139","LABU","FTH","BK4581","BK4585","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648274683","title":"Arcturus, Thermo Fisher deal adds support to ARCT-032 exposure, says Roth","url":"https://stock-news.laohu8.com/highlight/detail?id=2648274683","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648274683?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:55","pubTimestamp":1783000529,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Adam Walsh keeps a Buy rating and $20 price target on shares of Arcturus Therapeutics (ARCT). The Thermo Fisher (TMO) collabor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcturus-thermo-fisher-deal-adds-support-to-arct-032-exposure-says-roth-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcturus-thermo-fisher-deal-adds-support-to-arct-032-exposure-says-roth-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","LU0316494557.USD","LU1803068623.USD","LU2125909247.SGD","IE00BQXX3D17.EUR","LU1548497426.USD","LU0823416689.USD","LU0528227936.USD","LU0061474960.USD","TMO","IE00BKPKM429.USD","LU0114720955.EUR","LU1989771016.USD","LU2543165471.USD","LU2125910179.SGD","LU2468319806.SGD","LU0011850046.USD","LU2125909916.SGD","LU2125909759.SGD","LU1854104046.USD","BK4534","IE0002141913.USD","LU0122379950.USD","LU2092937221.SGD","LU1923622614.USD","LU2211814178.USD","LU1280957306.USD","LU2360108059.USD","IE00BQXX3F31.USD","LU0882574055.USD","IE0034235188.USD","LU1670628061.USD","ARCT","LU2089984988.USD","LU1988902786.USD","LU0957791311.USD","LU0345770993.USD","LU0208291251.USD","GB00BDT5M118.USD","LU1720051108.HKD","IE00B4R5TH58.HKD","LU2764263039.SGD","BK4535","BK4139","BK4588","LU0266013472.USD","IE00B2B36J28.USD","LU0096362180.USD","LU2720916845.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":0.211},{"period":"1month","weight":1.0621},{"period":"3month","weight":1.2483},{"period":"6month","weight":1.5535},{"period":"1year","weight":-0.062},{"period":"ytd","weight":1.7618}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0063},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.1758},{"period":"1year","weight":0.1569},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.084619},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016903},{"month":3,"riseRate":0.230769,"avgChangeRate":-0.051078},{"month":4,"riseRate":0.615385,"avgChangeRate":0.111259},{"month":5,"riseRate":0.538462,"avgChangeRate":0.081426},{"month":6,"riseRate":0.571429,"avgChangeRate":0.011692},{"month":7,"riseRate":0.5,"avgChangeRate":0.079293},{"month":8,"riseRate":0.571429,"avgChangeRate":0.178945},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.038208},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.077832},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033635},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.064746}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Arcturus Therapeutics Ltd.(ARCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Arcturus Therapeutics Ltd.(ARCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction